Clinical trials are using AI to handle large and complex volumes of data to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data.
In recent years, there has been significant interest and investment in the potential of artificial intelligence (AI) and machine learning (ML) to significantly impact the field of pharmaceutical research and development (R&D).
Artificial intelligence has been driven by advances in computational technology, resulting in an expanded ability to collect and process large volumes of data, which have been essential in drug discovery.